• General multiple sclerosis (MS)
  • MS - Dimethyl fumarate
  • MS - Natalizumab
  • MS - Peginterferon beta-1a
  • MS - Prolonged-release fampridine
    • The area of research currently being considered to support studies related to prolonged-release fampridine,
      only to be conducted outside of the United States, can be found below.

      1. Impact of prolonged-release fampridine predominantly seen in real-world measures
         

      Of note: Study designs for research objectives that have been well-researched in the past need to be powered to derive statistically meaningful conclusions and provide new scientific observations.

      Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee that support will be awarded.